GuidelineCurrent
ACC/AHA/ACCP/HRS 2023 — 2023 Guideline for the Diagnosis and Management of Atrial Fibrillation
American College of Cardiology / American Heart Association / American College of Clinical Pharmacy / Heart Rhythm Society, 2023
Recognizes AF as a progressive disease with staged management (risk factors through permanent AF), with recommendations spanning thromboembolic risk assessment and anticoagulation, rate and rhythm control strategies, and catheter/surgical ablation. Early rhythm control is associated with better maintenance of sinus rhythm and reduced AF progression in appropriate candidates.
Conditional recommendationModerate certainty
View source guideline